Abound Financial’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$62.8K Sell
215
-10
-4% -$3.29K 0.03% 105
2025
Q4
$78.7K Buy
+225
New +$76K 0.03% 98
2025
Q2
Sell
-405
Closed -$176K 126
2025
Q1
$176K Buy
+405
New +$163K 0.09% 72

Other funds holding ELV

Abound Financial's ELV Position: Q1 2026 in Review

Abound Financial reduced its Elevance Health (ELV) stake by 4.4% in Q1 2026, selling an estimated $3.29K and leaving 215 shares worth $62.8K. The position accounts for 0.03% of the portfolio, ranked #105.

Abound Financial first reported a position in ELV in Q1 2025 and has held it in 3 quarters since. The position peaked at $176K in Q1 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Abound Financial held 215 shares of Elevance Health worth $62.8K as of Q1 2026.
  • Abound Financial sold 10 Elevance Health shares in Q1 2026, an estimated $3.29K.
  • Elevance Health made up 0.03% of Abound Financial's portfolio in Q1 2026, its #105 holding.
  • Abound Financial first reported a position in Elevance Health in Q1 2025 and has held it in 3 quarters since.
  • Abound Financial's Elevance Health position peaked at $176K in Q1 2025.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Abound Financial's 13F filing for Q1 2026, filed 4 May 2026.